Headline
The latest stories from AHA Today.
The White House Aug. 13 released an executive order directing the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response to develop a list of 26 drugs considered critical for national health and security.
The Centers for Medicare & Medicaid Services has issued the 2025-2026 Medicaid Managed Care Rate Development Guide for states to use when setting managed care capitation rates for the rating periods between July 1, 2025, and June 30, 2026.
Josh Neff, CEO of CommonSpirit Mercy Hospital, discusses a new cutting-edge communication platform that sends patient EKGs directly from the ambulance to the cardiologist in real time. Neff explains how this simple, affordable tool is cutting treatment times and saving lives in one of the nation’s…
The AHA on Aug. 14 at 1 p.m. ET will host a webinar on age-friendly health systems and how they can strengthen care delivery.
The Food and Drug Administration has identified a Class I recall of Draeger SafeStar and TwinStar Filters due to a risk of misleading carbon dioxide readings.
Speakers interested in leading conversations at the AHA’s new Healthier Together Conference are advised to submit a content proposal by Sept. 16.
The AHA will host a webinar Aug. 13 from 1-2 p.m. ET that will explore strategies and proven de-escalation techniques unique to addressing workplace violence in health care settings.
The Department of Justice Aug. 11 announced a series of actions taken against the BlackSuit ransomware group, also known as “Royal,” including the disruption of four servers and nine domains July 24.
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease Control and Prevention Aug. 8. Wastewater levels for COVID-19 have been classified as moderate nationwide, with the highest detected in the…
The Food and Drug Administration Aug. 8 announced an end to the national shortage of sodium chloride 0.9% IV solutions products.